Insider files Form 144 to sell 30,000 Vanda Pharma shares (VNDA)

Rhea-AI Filing Summary

Vanda Pharmaceuticals reported a Form 144 stating intended sales of Common Stock totaling 30,000 shares. The filing lists planned vesting/settlement amounts of 6,602 shares on 03/15/2024, 17,307 shares on 06/08/2024, and 6,091 shares on 03/15/2025.

Insights

Securities Counsel

Form 144 is a notice of intended sale under resale rules for restricted stock.

The excerpt lists intended sales of Common Stock totaling 30,000 shares with specific settlement dates: 03/15/2024, 06/08/2024, and 03/15/2025

Transaction timing and method are not detailed in the excerpt; subsequent filings will show actual sale execution and any broker/dealer involvement.

Equity Compensation Specialist

The items appear to be vesting/settlement of restricted stock units reported for resale.

The filing identifies three settlement events totaling 30,000 shares, each labeled "Vesting / Settlement of Restricted Stock Units" and assigned to the issuer as the source.

Cash proceeds treatment and whether withholding shares will be sold are not shown in the excerpt; reader should consult later trade reports for executed volumes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 1152 15th Street, N.W. Suite 6000 Washington DC 20005	30000	240900	59108030	02/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/15/2024	Vesting / Settlement of Restricted Stock Units	Issuer			6602	03/15/2024	Compensation
Common Stock	06/08/2024	Vesting / Settlement of Restricted Stock Units	Issuer			17307	06/08/2024	Compensation
Common Stock	03/15/2025	Vesting / Settlement of Restricted Stock Units	Issuer			6091	03/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the VNDA Form 144 report?

It reports intended sales of 30,000 Common Stock shares. The filing lists vesting/settlement amounts of 6,602, 17,307, and 6,091 on 03/15/2024, 06/08/2024, and 03/15/2025.

Do the Form 144 entries indicate who will sell the shares for VNDA?

The excerpt attributes the securities to the issuer in connection with RSU vesting/settlement. The filing lines show "Issuer" as the source for each listed vesting/settlement amount.

Are the settlement dates for the VNDA shares disclosed?

Yes. The excerpt lists settlement/vesting dates of 03/15/2024, 06/08/2024, and 03/15/2025 tied to the respective share amounts.

Does the Form 144 show actual sales have occurred for VNDA?

No; it shows intended sales tied to RSU settlements. The excerpt lists planned vesting/settlement amounts and dates but does not report executed trade details.